A.R.T. Advisors’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-15,681
Closed -$486K 1507
2019
Q1
$486K Buy
+15,681
New +$418K 0.03% 750
2018
Q4
Sell
-5,476
Closed -$212K 1510
2018
Q3
$212K Sell
5,476
-20,600
-79% -$742K 0.01% 1170
2018
Q2
$873K Buy
+26,076
New +$928K 0.04% 693
2017
Q3
Sell
-7,900
Closed -$246K 1512
2017
Q2
$246K Buy
+7,900
New +$228K 0.01% 1086
2017
Q1
Sell
-10,500
Closed -$266K 1583
2016
Q4
$266K Buy
+10,500
New +$233K 0.02% 977
2016
Q3
Sell
-16,233
Closed -$231K 923
2016
Q2
$231K Sell
16,233
-2,800
-15% -$42.8K 0.01% 1054
2016
Q1
$295K Buy
+19,033
New +$273K 0.01% 1053

Other funds holding LMAT

A.R.T. Advisors's LMAT Position: Q2 2019 in Review

A.R.T. Advisors sold out of LeMaitre Vascular (LMAT) in Q2 2019, closing a stake of 15,681 shares — an estimated $486K sold.

A.R.T. Advisors first reported a position in LMAT in Q1 2016 and held it in 7 quarters. The position peaked at $873K in Q2 2018. 150 funds tracked by Wall St. Rank hold LMAT as of Q2 2019.

  • A.R.T. Advisors reported no remaining LeMaitre Vascular position as of Q2 2019 after selling out during the quarter.
  • A.R.T. Advisors sold 15,681 LeMaitre Vascular shares in Q2 2019, an estimated $486K.
  • A.R.T. Advisors first reported a position in LeMaitre Vascular in Q1 2016 and held it in 7 quarters.
  • A.R.T. Advisors's LeMaitre Vascular position peaked at $873K in Q2 2018.
  • 150 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2019.

Based on A.R.T. Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.